| Pharmaceutical active ingredients: |
| Moxonidine |
| Available forms, composition and doses of Normoxocin: |
| N / A |
| Normoxocin medical category: |
| Human:AntihypertensivesImidazoline receptors subtype 1 agonists |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C02AC05 - Moxonidine |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Normon | Ranitidine | Unidentified Pharmaceutical Company |
| Normonson | Ethchlorvynol | Unidentified Pharmaceutical Company |
| Normorescina | Rescinnamine | Unidentified Pharmaceutical Company |
| Normosan | Ethchlorvynol | Unidentified Pharmaceutical Company |
| Normoson | Ethchlorvynol | Unidentified Pharmaceutical Company |
| Normurat | Benzbromarone | Unidentified Pharmaceutical Company |
| Norobrittin | Ampicillin | Unidentified Pharmaceutical Company |
| Norocaine | Procaine | Unidentified Pharmaceutical Company |
| Norofilina | Aminophylline | Unidentified Pharmaceutical Company |
| Norpolake | Desipramine | Unidentified Pharmaceutical Company |